Proactiveinvestors Australia Shield Therapeutics PLC https://www.proactiveinvestors.com.au Proactiveinvestors Australia Shield Therapeutics PLC RSS feed en Thu, 14 Nov 2019 00:04:00 +1100 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) Shield Therapeutics: Analyst discusses further positive data from non-inferiority Feraccru study https://www.proactiveinvestors.com.au/companies/news/906058/shield-therapeutics-analyst-discusses-further-positive-data-from-non-inferiority-feraccru-study-906058.html Thu, 31 Oct 2019 09:42:00 +1100 https://www.proactiveinvestors.com.au/companies/news/906058/shield-therapeutics-analyst-discusses-further-positive-data-from-non-inferiority-feraccru-study-906058.html Shield Therapeutics PLC: Hitting its clinical targets https://www.proactiveinvestors.com.au/companies/news/905848/shield-therapeutics-plc-hitting-its-clinical-targets-905848.html Tue, 29 Oct 2019 14:44:31 +1100 https://www.proactiveinvestors.com.au/companies/news/905848/shield-therapeutics-plc-hitting-its-clinical-targets-905848.html Shield Therapeutics: All eyes on the US after FDA approval https://www.proactiveinvestors.com.au/companies/news/900636/shield-therapeutics-all-eyes-on-the-us-after-fda-approval-900636.html Tue, 29 Oct 2019 12:34:00 +1100 https://www.proactiveinvestors.com.au/companies/news/900636/shield-therapeutics-all-eyes-on-the-us-after-fda-approval-900636.html Proactive snapshot: Collagen, Haydale Graphene, Arecor https://www.proactiveinvestors.com.au/companies/news/905332/proactive-snapshot-collagen-haydale-graphene-arecor-905332.html Tue, 22 Oct 2019 14:30:00 +1100 https://www.proactiveinvestors.com.au/companies/news/905332/proactive-snapshot-collagen-haydale-graphene-arecor-905332.html Shield Therapeutics to present data showing Feraccru offers 'real oral alternative' https://www.proactiveinvestors.com.au/companies/news/905322/shield-therapeutics-to-present-data-showing-feraccru-offers--real-oral-alternative--905322.html Tue, 22 Oct 2019 08:11:00 +1100 https://www.proactiveinvestors.com.au/companies/news/905322/shield-therapeutics-to-present-data-showing-feraccru-offers--real-oral-alternative--905322.html Shield Therapeutics to present phase IIIb study data to key opinion leaders https://www.proactiveinvestors.com.au/companies/news/905305/shield-therapeutics-to-present-phase-iiib-study-data-to-key-opinion-leaders-905305.html Tue, 22 Oct 2019 06:45:00 +1100 https://www.proactiveinvestors.com.au/companies/news/905305/shield-therapeutics-to-present-phase-iiib-study-data-to-key-opinion-leaders-905305.html Shield Therapeutics 'in a strong position' and confident of a US Feraccru deal https://www.proactiveinvestors.com.au/companies/news/900351/shield-therapeutics--in-a-strong-position--and-confident-of-a-us-feraccru-deal-900351.html Thu, 08 Aug 2019 07:40:00 +1000 https://www.proactiveinvestors.com.au/companies/news/900351/shield-therapeutics--in-a-strong-position--and-confident-of-a-us-feraccru-deal-900351.html Broad label approval is 'best possible outcome' for Shield Therapeutics' Feraccru https://www.proactiveinvestors.com.au/companies/news/900120/broad-label-approval-is--best-possible-outcome--for-shield-therapeutics--feraccru-900120.html Mon, 05 Aug 2019 11:54:00 +1000 https://www.proactiveinvestors.com.au/companies/news/900120/broad-label-approval-is--best-possible-outcome--for-shield-therapeutics--feraccru-900120.html Shield looking to exploit 'significant' market opportunity after US approval for Feraccru https://www.proactiveinvestors.com.au/companies/news/314276/shield-looking-to-exploit--significant--market-opportunity-after-us-approval-for-feraccru-14276.html Wed, 31 Jul 2019 08:16:00 +1000 https://www.proactiveinvestors.com.au/companies/news/314276/shield-looking-to-exploit--significant--market-opportunity-after-us-approval-for-feraccru-14276.html Shield Therapeutics PLC: FDA approves broad label for Feraccru https://www.proactiveinvestors.com.au/companies/news/430679/shield-therapeutics-plc-fda-approves-broad-label-for-feraccru-430679.html Mon, 29 Jul 2019 14:00:00 +1000 https://www.proactiveinvestors.com.au/companies/news/430679/shield-therapeutics-plc-fda-approves-broad-label-for-feraccru-430679.html Shield Therapeutics hails 'enormous' achievement of US regulatory approval https://www.proactiveinvestors.com.au/companies/news/314219/shield-therapeutics-hails--enormous--achievement-of-us-regulatory-approval-14219.html Fri, 26 Jul 2019 11:31:00 +1000 https://www.proactiveinvestors.com.au/companies/news/314219/shield-therapeutics-hails--enormous--achievement-of-us-regulatory-approval-14219.html Shield Therapeutics adds two-thirds to its value after receiving US approval for flagship product https://www.proactiveinvestors.com.au/companies/news/224549/shield-therapeutics-adds-two-thirds-to-its-value-after-receiving-us-approval-for-flagship-product-224549.html Fri, 26 Jul 2019 11:21:00 +1000 https://www.proactiveinvestors.com.au/companies/news/224549/shield-therapeutics-adds-two-thirds-to-its-value-after-receiving-us-approval-for-flagship-product-224549.html Shield Therapeutics to continue “robust” defence of IP as Teva appeals Feraccru ruling https://www.proactiveinvestors.com.au/companies/news/221361/shield-therapeutics-to-continue-robust-defence-of-ip-as-teva-appeals-feraccru-ruling-221361.html Mon, 03 Jun 2019 08:40:00 +1000 https://www.proactiveinvestors.com.au/companies/news/221361/shield-therapeutics-to-continue-robust-defence-of-ip-as-teva-appeals-feraccru-ruling-221361.html Shield's Feraccru likely to command 'high market share and branded pricing' https://www.proactiveinvestors.com.au/companies/news/330179/shield-s-feraccru-likely-to-command-high-market-share-and-branded-pricing--0179.html Fri, 10 May 2019 14:17:00 +1000 https://www.proactiveinvestors.com.au/companies/news/330179/shield-s-feraccru-likely-to-command-high-market-share-and-branded-pricing--0179.html Shield's Feraccru likely to command 'high market share and branded pricing' https://www.proactiveinvestors.com.au/companies/news/313300/shield-s-feraccru-likely-to-command--high-market-share-and-branded-pricing--13300.html Fri, 10 May 2019 14:17:00 +1000 https://www.proactiveinvestors.com.au/companies/news/313300/shield-s-feraccru-likely-to-command--high-market-share-and-branded-pricing--13300.html Shield Therapeutics primed for a busy year https://www.proactiveinvestors.com.au/companies/news/219980/shield-therapeutics-primed-for-a-busy-year-219980.html Thu, 09 May 2019 11:51:00 +1000 https://www.proactiveinvestors.com.au/companies/news/219980/shield-therapeutics-primed-for-a-busy-year-219980.html Shield Therapeutics PLC Heading for a US approval decision https://www.proactiveinvestors.com.au/companies/news/430671/shield-therapeutics-plc-heading-for-a-us-approval-decision-430671.html Thu, 09 May 2019 10:50:00 +1000 https://www.proactiveinvestors.com.au/companies/news/430671/shield-therapeutics-plc-heading-for-a-us-approval-decision-430671.html Swiss broad label approval 'a further endorsement' of Shield's Feraccru drug https://www.proactiveinvestors.com.au/companies/news/313130/swiss-broad-label-approval--a-further-endorsement--of-shield-s-feraccru-drug-13130.html Mon, 29 Apr 2019 10:53:00 +1000 https://www.proactiveinvestors.com.au/companies/news/313130/swiss-broad-label-approval--a-further-endorsement--of-shield-s-feraccru-drug-13130.html Shield Therapeutics wins extended approval for Feraccru in Switzerland https://www.proactiveinvestors.com.au/companies/news/219006/shield-therapeutics-wins-extended-approval-for-feraccru-in-switzerland-219006.html Wed, 24 Apr 2019 10:45:00 +1000 https://www.proactiveinvestors.com.au/companies/news/219006/shield-therapeutics-wins-extended-approval-for-feraccru-in-switzerland-219006.html Dr John Mansfield discusses non-inferiority trial of Shield Therapeutics' Feraccru drug https://www.proactiveinvestors.com.au/companies/news/312909/dr-john-mansfield-discusses-non-inferiority-trial-of-shield-therapeutics--feraccru-drug-12909.html Mon, 08 Apr 2019 10:48:00 +1000 https://www.proactiveinvestors.com.au/companies/news/312909/dr-john-mansfield-discusses-non-inferiority-trial-of-shield-therapeutics--feraccru-drug-12909.html Shield's flagship iron pill goes from strength to strength https://www.proactiveinvestors.com.au/companies/news/312871/shield-s-flagship-iron-pill-goes-from-strength-to-strength-12871.html Thu, 04 Apr 2019 13:54:00 +1100 https://www.proactiveinvestors.com.au/companies/news/312871/shield-s-flagship-iron-pill-goes-from-strength-to-strength-12871.html Shield Therapeutics targeting more lucrative Feraccru out-licence deals in 2019 https://www.proactiveinvestors.com.au/companies/news/217840/shield-therapeutics-targeting-more-lucrative-feraccru-out-licence-deals-in-2019-217840.html Wed, 03 Apr 2019 11:05:00 +1100 https://www.proactiveinvestors.com.au/companies/news/217840/shield-therapeutics-targeting-more-lucrative-feraccru-out-licence-deals-in-2019-217840.html Shield Therapeutics says European Patent Office decides in company’s favour in relation to a Feracru patent https://www.proactiveinvestors.com.au/companies/news/216501/shield-therapeutics-says-european-patent-office-decides-in-companys-favour-in-relation-to-a-feracru-patent-216501.html Thu, 14 Mar 2019 15:49:00 +1100 https://www.proactiveinvestors.com.au/companies/news/216501/shield-therapeutics-says-european-patent-office-decides-in-companys-favour-in-relation-to-a-feracru-patent-216501.html Shield Therapeutics CEO hails positive head-to-head Feraccru study results https://www.proactiveinvestors.com.au/companies/news/312429/shield-therapeutics-ceo-hails-positive-head-to-head-feraccru-study-results-12429.html Mon, 04 Mar 2019 14:33:00 +1100 https://www.proactiveinvestors.com.au/companies/news/312429/shield-therapeutics-ceo-hails-positive-head-to-head-feraccru-study-results-12429.html Shield Therapeutics’ Feraccru iron deficiency drug shows its mettle in head-to-head study https://www.proactiveinvestors.com.au/companies/news/215689/shield-therapeutics-feraccru-iron-deficiency-drug-shows-its-mettle-in-head-to-head-study-215689.html Mon, 04 Mar 2019 08:09:00 +1100 https://www.proactiveinvestors.com.au/companies/news/215689/shield-therapeutics-feraccru-iron-deficiency-drug-shows-its-mettle-in-head-to-head-study-215689.html Shield Therapeutics CEO delighted with further positive results from pivotal Feraccru study https://www.proactiveinvestors.com.au/companies/news/312035/shield-therapeutics-ceo-delighted-with-further-positive-results-from-pivotal-feraccru-study-12035.html Wed, 30 Jan 2019 12:28:00 +1100 https://www.proactiveinvestors.com.au/companies/news/312035/shield-therapeutics-ceo-delighted-with-further-positive-results-from-pivotal-feraccru-study-12035.html Shield Therapeutics' shares rise as it hails results of extended trial of Feraccru https://www.proactiveinvestors.com.au/companies/news/213497/shield-therapeutics--shares-rise-as-it-hails-results-of-extended-trial-of-feraccru-213497.html Tue, 29 Jan 2019 11:15:00 +1100 https://www.proactiveinvestors.com.au/companies/news/213497/shield-therapeutics--shares-rise-as-it-hails-results-of-extended-trial-of-feraccru-213497.html Shield Therapeutics funded through to 2020 https://www.proactiveinvestors.com.au/companies/news/213232/shield-therapeutics-funded-through-to-2020-213232.html Thu, 24 Jan 2019 09:27:00 +1100 https://www.proactiveinvestors.com.au/companies/news/213232/shield-therapeutics-funded-through-to-2020-213232.html Shield Therapeutics appoints Karis as chairman https://www.proactiveinvestors.com.au/companies/news/213038/shield-therapeutics-appoints-karis-as-chairman-213038.html Tue, 22 Jan 2019 13:50:00 +1100 https://www.proactiveinvestors.com.au/companies/news/213038/shield-therapeutics-appoints-karis-as-chairman-213038.html Shield Therapeutics' Feraccru drug 'a potential game-changer' https://www.proactiveinvestors.com.au/companies/news/311921/shield-therapeutics--feraccru-drug--a-potential-game-changer--11921.html Mon, 21 Jan 2019 13:36:00 +1100 https://www.proactiveinvestors.com.au/companies/news/311921/shield-therapeutics--feraccru-drug--a-potential-game-changer--11921.html Shield Therapeutics' Feraccru drug 'a potential game-changer' https://www.proactiveinvestors.com.au/companies/news/330146/shield-therapeutics-feraccru-drug-a-potential-game-changer--0146.html Mon, 21 Jan 2019 11:05:00 +1100 https://www.proactiveinvestors.com.au/companies/news/330146/shield-therapeutics-feraccru-drug-a-potential-game-changer--0146.html Shield Therapeutics PLC - Feraccru: a potential game changer in the treatment of iron deficiency anaemia https://www.proactiveinvestors.com.au/companies/news/430648/shield-therapeutics-plc---feraccru-a-potential-game-changer-in-the-treatment-of-iron-deficiency-anaemia-430648.html Fri, 18 Jan 2019 09:40:00 +1100 https://www.proactiveinvestors.com.au/companies/news/430648/shield-therapeutics-plc---feraccru-a-potential-game-changer-in-the-treatment-of-iron-deficiency-anaemia-430648.html Medical expert discusses his experience working with Shield Therapeutics' Feraccru drug https://www.proactiveinvestors.com.au/companies/news/311863/medical-expert-discusses-his-experience-working-with-shield-therapeutics--feraccru-drug-11863.html Wed, 16 Jan 2019 08:50:00 +1100 https://www.proactiveinvestors.com.au/companies/news/311863/medical-expert-discusses-his-experience-working-with-shield-therapeutics--feraccru-drug-11863.html US FDA to make decision on Shield Therapeutics’ Feraccru drug by end of July https://www.proactiveinvestors.com.au/companies/news/211119/us-fda-to-make-decision-on-shield-therapeutics-feraccru-drug-by-end-of-july-211119.html Thu, 13 Dec 2018 14:15:00 +1100 https://www.proactiveinvestors.com.au/companies/news/211119/us-fda-to-make-decision-on-shield-therapeutics-feraccru-drug-by-end-of-july-211119.html Shield Therapeutics to expand iron deficiency treatment with child trials in 2019 https://www.proactiveinvestors.com.au/companies/news/311582/shield-therapeutics-to-expand-iron-deficiency-treatment-with-child-trials-in-2019-11582.html Tue, 11 Dec 2018 14:18:00 +1100 https://www.proactiveinvestors.com.au/companies/news/311582/shield-therapeutics-to-expand-iron-deficiency-treatment-with-child-trials-in-2019-11582.html Shield Therapeutics PLC expecting US decision on Feraccru around July https://www.proactiveinvestors.com.au/companies/news/311428/shield-therapeutics-plc-expecting-us-decision-on-feraccru-around-july-11428.html Tue, 04 Dec 2018 13:16:00 +1100 https://www.proactiveinvestors.com.au/companies/news/311428/shield-therapeutics-plc-expecting-us-decision-on-feraccru-around-july-11428.html Shield Therapeutics' Feraccru to be considered for US market by the FDA https://www.proactiveinvestors.com.au/companies/news/210378/shield-therapeutics--feraccru-to-be-considered-for-us-market-by-the-fda-210378.html Mon, 03 Dec 2018 13:37:00 +1100 https://www.proactiveinvestors.com.au/companies/news/210378/shield-therapeutics--feraccru-to-be-considered-for-us-market-by-the-fda-210378.html Shield Therapeutics sees big opportunities for its iron deficiency treatment Feraccru https://www.proactiveinvestors.com.au/companies/news/311365/shield-therapeutics-sees-big-opportunities-for-its-iron-deficiency-treatment-feraccru-11365.html Thu, 29 Nov 2018 11:33:00 +1100 https://www.proactiveinvestors.com.au/companies/news/311365/shield-therapeutics-sees-big-opportunities-for-its-iron-deficiency-treatment-feraccru-11365.html Shield Therapeutics slumps as flagship drug fails pivotal Phase III trial https://www.proactiveinvestors.com.au/companies/news/191149/shield-therapeutics-slumps-as-flagship-drug-fails-pivotal-phase-iii-trial-191149.html Mon, 05 Feb 2018 11:52:00 +1100 https://www.proactiveinvestors.com.au/companies/news/191149/shield-therapeutics-slumps-as-flagship-drug-fails-pivotal-phase-iii-trial-191149.html Shield Therapeutics to raise £12mln to fund further development and commercialisation of Feraccru https://www.proactiveinvestors.com.au/companies/news/179313/shield-therapeutics-to-raise-12mln-to-fund-further-development-and-commercialisation-of-feraccru-179313.html Thu, 15 Jun 2017 09:08:00 +1000 https://www.proactiveinvestors.com.au/companies/news/179313/shield-therapeutics-to-raise-12mln-to-fund-further-development-and-commercialisation-of-feraccru-179313.html